BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 28664505)

  • 21. In vitro modeling of experimental succinic semialdehyde dehydrogenase deficiency (SSADHD) using brain-derived neural stem cells.
    Vogel KR; Ainslie GR; Jansen EE; Salomons GS; Roullet JB; Gibson KM
    PLoS One; 2017; 12(10):e0186919. PubMed ID: 29053743
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Succinic semialdehyde dehydrogenase deficiency, a disorder of GABA metabolism: an update on pharmacological and enzyme-replacement therapeutic strategies.
    Vogel KR; Ainslie GR; Walters DC; McConnell A; Dhamne SC; Rotenberg A; Roullet JB; Gibson KM
    J Inherit Metab Dis; 2018 Jul; 41(4):699-708. PubMed ID: 29460030
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Toxicologic/transport properties of NCS-382, a γ-hydroxybutyrate (GHB) receptor ligand, in neuronal and epithelial cells: Therapeutic implications for SSADH deficiency, a GABA metabolic disorder.
    Vogel KR; Ainslie GR; McConnell A; Roullet JB; Gibson KM
    Toxicol In Vitro; 2018 Feb; 46():203-212. PubMed ID: 29031482
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical and molecular outcomes from the 5-Year natural history study of SSADH Deficiency, a model metabolic neurodevelopmental disorder.
    Tokatly Latzer I; Roullet JB; Afshar-Saber W; Lee HHC; Bertoldi M; McGinty GE; DiBacco ML; Arning E; Tsuboyama M; Rotenberg A; Opladen T; Jeltsch K; García-Cazorla À; Juliá-Palacios N; Gibson KM; Sahin M; Pearl PL
    J Neurodev Disord; 2024 Apr; 16(1):21. PubMed ID: 38658850
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Identification of ALDH5A1 gene mutations in a Chinese family affected with succinic semialdehyde dehydrogenase deficiency].
    Shu J; Cai F; Fan W; Meng Y; Zhang C; Cai C; Zhang Y; Lin S
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2017 Feb; 34(1):6-9. PubMed ID: 28186584
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute Infantile Encephalopathy as Presentation of Succinic Semialdehyde Dehydrogenase Deficiency.
    Zeiger WA; Sun LR; Bosemani T; Pearl PL; Stafstrom CE
    Pediatr Neurol; 2016 May; 58():113-5. PubMed ID: 27268762
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Succinic Semialdehyde Dehydrogenase Deficiency in a Chinese Boy: A Novel ALDH5A1 Mutation With Severe Phenotype.
    Tay CG; Ariffin H; Yap S; Rahmat K; Sthaneshwar P; Ong LC
    J Child Neurol; 2015 Jun; 30(7):927-31. PubMed ID: 25122112
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Analysis of ALDH5A1 gene mutation in a Chinese Han family with succinic semialdehyde dehydrogenase deficiency].
    Jiang SZ; Shu JB; Zhang YQ; Fan WX; Meng YT; Song L
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2013 Aug; 30(4):389-93. PubMed ID: 23926001
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Succinic semialdehyde dehydrogenase (SSADH) deficiency: Molecular analysis in a South American family.
    Lemes A; Blasi P; Gonzales G; Russi ME; Quadrelli R; Novelletto A; Malaspina P
    J Inherit Metab Dis; 2006 Aug; 29(4):587. PubMed ID: 16788854
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative genomics of aldehyde dehydrogenase 5a1 (succinate semialdehyde dehydrogenase) and accumulation of gamma-hydroxybutyrate associated with its deficiency.
    Malaspina P; Picklo MJ; Jakobs C; Snead OC; Gibson KM
    Hum Genomics; 2009 Jan; 3(2):106-20. PubMed ID: 19164088
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Succinic semialdehyde dehydrogenase: biochemical-molecular-clinical disease mechanisms, redox regulation, and functional significance.
    Kim KJ; Pearl PL; Jensen K; Snead OC; Malaspina P; Jakobs C; Gibson KM
    Antioxid Redox Signal; 2011 Aug; 15(3):691-718. PubMed ID: 20973619
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Succinic semialdehyde dehydrogenase deficiency: GABAB receptor-mediated function.
    Buzzi A; Wu Y; Frantseva MV; Perez Velazquez JL; Cortez MA; Liu CC; Shen LQ; Gibson KM; Snead OC
    Brain Res; 2006 May; 1090(1):15-22. PubMed ID: 16647690
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation of blood biomarkers with age informs pathomechanisms in succinic semialdehyde dehydrogenase deficiency (SSADHD), a disorder of GABA metabolism.
    Jansen EE; Vogel KR; Salomons GS; Pearl PL; Roullet JB; Gibson KM
    J Inherit Metab Dis; 2016 Nov; 39(6):795-800. PubMed ID: 27686230
    [TBL] [Abstract][Full Text] [Related]  

  • 34. mTOR inhibitors rescue premature lethality and attenuate dysregulation of GABAergic/glutamatergic transcription in murine succinate semialdehyde dehydrogenase deficiency (SSADHD), a disorder of GABA metabolism.
    Vogel KR; Ainslie GR; Gibson KM
    J Inherit Metab Dis; 2016 Nov; 39(6):877-886. PubMed ID: 27518770
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutants of GABA transaminase (POP2) suppress the severe phenotype of succinic semialdehyde dehydrogenase (ssadh) mutants in Arabidopsis.
    Ludewig F; Hüser A; Fromm H; Beauclair L; Bouché N
    PLoS One; 2008; 3(10):e3383. PubMed ID: 18846220
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Succinic semialdehyde dehydrogenase deficiency in mice and in humans: An untargeted metabolomics perspective.
    Peters TMA; Engelke UFH; de Boer S; Reintjes JTG; Roullet JB; Broekman S; de Vrieze E; van Wijk E; Wamelink MMC; Artuch R; Barić I; Merx J; Boltje TJ; Martens J; Willemsen MAAP; Verbeek MM; Wevers RA; Gibson KM; Coene KLM
    J Inherit Metab Dis; 2024 May; 47(3):417-430. PubMed ID: 37455357
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ALDH5A1-deficient iPSC-derived excitatory and inhibitory neurons display cell type specific alterations.
    Afshar-Saber W; Teaney NA; Winden KD; Jumo H; Shi X; McGinty G; Hubbs J; Chen C; Tokatly Latzer I; Gasparoli F; Ebrahimi-Fakhari D; Buttermore ED; Roullet JB; Pearl PL; Sahin M
    Neurobiol Dis; 2024 Jan; 190():106386. PubMed ID: 38110041
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bi-allelic Mutations in ALDH5A1 is associated with succinic semialdehyde dehydrogenase deficiency and severe intellectual disability.
    Fattahi M; Bushehri A; Alavi A; Asghariazar V; Nozari A; Ghasemi Firouzabadi S; Motamedian Dehkordi P; Javid M; Farajzadeh Valiliou S; Karimian J; Behjati F
    Gene; 2020 Jul; ():144918. PubMed ID: 32621952
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 4-Hydroxybutyric acid and the clinical phenotype of succinic semialdehyde dehydrogenase deficiency, an inborn error of GABA metabolism.
    Gibson KM; Hoffmann GF; Hodson AK; Bottiglieri T; Jakobs C
    Neuropediatrics; 1998 Feb; 29(1):14-22. PubMed ID: 9553943
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapeutic intervention in mice deficient for succinate semialdehyde dehydrogenase (gamma-hydroxybutyric aciduria).
    Gupta M; Greven R; Jansen EE; Jakobs C; Hogema BM; Froestl W; Snead OC; Bartels H; Grompe M; Gibson KM
    J Pharmacol Exp Ther; 2002 Jul; 302(1):180-7. PubMed ID: 12065715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.